Inission Q2 FY26 EBITA rises 16.8% to SEK 41 million; net sales climb 18.7% to SEK 635 million
Reuters2026/08/26 08:48- Inission posted Q2 2026 net sales of SEK 635 million, up 18.7% year on year, while EBITA rose to SEK 41 million.
- EBITA margin widened 1.9 percentage points to 6.4%, while earnings per share increased to SEK 1.3.
- EMS unit net sales climbed to SEK 546 million, up 18.9%, while EBITA increased to SEK 36.4 million and margin edged up to 6.7%.
- Enedo net sales rose to SEK 89 million, up 17.7%, while EBITA swung to a profit of SEK 3.8 million.
- Quarter updates included the launch of Inission Power, a 1.9% minority stake purchase in Inission Norge, and a flexible robotics partnership at Inission Lökken.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
